Bulletin 2011/31 - European Patent Office
06.01.2013 • Views
Share Embed Flag

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

Bulletin 2011/31 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) I.1(2)<br />

• Vaccins incluant du NadA oligomère de la<br />

méningococcie pour une protection élargie<br />

contre des lignées hypervirulentes<br />

(71) Novartis Vaccines and Diagnostics S.r.l., Via<br />

Fiorentina 1, 5<strong>31</strong>00 Siena (SI), IT<br />

(72) Pizza, Mariagrazia, 5<strong>31</strong>00, Siena, IT<br />

(74) Marshall, Cameron John, Carpmaels &<br />

Ransford One Southampton Row, London<br />

WC1B 5HA, GB<br />

(62) 03758486.9 / 1 549 338<br />

A61K 39/095 → (51) A61K 39/385<br />

A61K 39/095 → (51) C07K 1/00<br />

A61K 39/102 → (51) A61K 39/095<br />

A61K 39/116 → (51) A61K 39/095<br />

A61K 39/116 → (51) A61K 39/385<br />

(51) A61K 39/12 (11) 2 351 580 A1<br />

C07K 14/235 C12N 9/88<br />

C07K 14/025<br />

(25) En (26) En<br />

(21) 10181329.3 (22) 18.03.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(27) 18.03.2005 PCT/EP2005/003452<br />

(30) 18.03.2004 EP 04290741<br />

(54) • Rekombinante Proteine, die Epitope des<br />

humanen Papillomavirus inseriert in einem<br />

Adenylatecyclase Protein oder in dessen<br />

Fragmenten tragen, und deren therapeutische<br />

Verwendung<br />

• Recombinant protein carrying human<br />

papillomavirus epitopes inserted in an<br />

adenylate cyclase protein or fragment<br />

thereof. therapeutic uses thereof<br />

• Proteines recombinantes, qui contiennent<br />

des epitopes du papillomavirus humaine<br />

inserees dans une proteine adenylate<br />

cyclase ou dans un fragment de celle-ci et<br />

leur utilization therapeutiques.<br />

(71) Institut Pasteur, 25-28 rue du Docteur Roux,<br />

75724 Paris Cédex 15, FR<br />

GENTICEL, Rue Pierre et Marie Curie Prologue<br />

Biotech, <strong>31</strong>670 Labège, FR<br />

Institut National de la Santé et de la<br />

Recherche Médicale, 101, rue de Tolbiac,<br />

75654 Paris Cedex 13, FR<br />

Centre National de la Recherche Scientifique,<br />

3, rue Michel-Ange, 75794 Paris Cedex 16,<br />

FR<br />

(72) Preville, Xavier Edmond Edouard, <strong>31</strong>570<br />

Préserville, FR<br />

Leclerc, Claude, 75015 Paris, FR<br />

Ladant, Daniel, 94230 Cachan, FR<br />

Timmerman, Benedikt, <strong>31</strong>000 Toulouse, FR<br />

(74) Desaix, Anne, et al, Ernest Gutmann - Yves<br />

Plasseraud S.A.S. 3, rue Auber, 75009 Paris,<br />

FR<br />

(62) 05728249.3 / 1 725 259<br />

A61K 39/12 → (51) C07K 14/08<br />

(51) A61K 39/135 (11) 2 351 581 A1<br />

A61P <strong>31</strong>/14<br />

(25) Zh (26) En<br />

(21) 09821602.1 (22) 23.10.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) CN 2009/074585 23.10.2009<br />

(87) WO 2010/045881 2010/17 29.04.2010<br />

(30) 24.10.2008 CN 200810172927<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • IMPFSTOFFZUSAMMENSETZUNG GEGEN<br />

MAUL- UND KLAUENSEUCHE SOWIE<br />

ZUBEREITUNGSVERFAHREN DAFÜR<br />

• A VACCINE COMPOSITION AGAINST<br />

FOOT-AND-MOUTH DISEASE AND THE<br />

PREPARATION METHOD THEREOF<br />

• COMPOSITION VACCINALE CONTRE LA<br />

FIÈVRE APHTEUSE ET PROCÉDÉ DE<br />

PRÉPARATION DE LADITE COMPOSITION<br />

VACCINALE<br />

(71) Ray Vaccine Limited, Suite 1201 Tower 2<br />

The Gateway 25 Canton Road Tsimshatsui,<br />

Kowloon, Hong Kong, CN<br />

(72) WANG, Yu, Haidian District Beijing 100097,<br />

CN<br />

(74) Kling, Simone, Lavoix Munich Bayerstrasse<br />

85a, 80335 München, DE<br />

A61K 39/145 → (51) C12N 7/02<br />

A61K 39/275 → (51) C07K 14/065<br />

A61K 39/29 → (51) C07K 14/02<br />

A61K 39/295 → (51) C07K 14/02<br />

(51) A61K 39/385 (11) 2 351 582 A1<br />

A61K 39/02 A61K 39/095<br />

A61K 39/116 C07H 1/00<br />

(25) En (26) En<br />

(21) 10187955.9 (22) 29.08.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK YU<br />

(30) 30.08.2004 US 605579 P<br />

(54) • Mehrwertige derivatisierte meningokokkale<br />

Polysaccharidproteinkonjugate und Vakzine<br />

• Multivalent meningococcal derivatized<br />

polysaccharide-protein conjugates and<br />

vaccine<br />

• Conjugués de polysaccharides-protéines<br />

dérivatisés méningococciques multivalents<br />

et vaccin<br />

(71) Sanofi Pasteur, Inc., One Discovery Drive<br />

Knerr Bldg., Swiftwater, PA 18370, US<br />

(72) Ryall, Robert P, East Stroudsburg, PA<br />

18302, US<br />

(74) Wilkinson, Marc George, HLBBshaw Merlin<br />

House Falconry Court Baker's Lane, Epping,<br />

Essex CM16 5DQ, GB<br />

(62) 05806584.8 / 1 784 214<br />

A61K 39/385 → (51) C07K 14/02<br />

(51) A61K 39/395 (11) 2 351 583 A1<br />

A61P 27/00 C07K 16/28<br />

C07K 16/42 C07K 16/46<br />

(25) En (26) En<br />

(21) 10012456.9 (22) 26.11.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(30) 26.11.2002 US 429743 P<br />

(54) • Chimäre und humanisierte Antikörper<br />

gegen Alpha5-beta1-Integrin zur Modulation<br />

von Angiogenese<br />

• Chimeric and humanized antibodies to<br />

alpha5 beta1 integrin that modulate<br />

angiogenesis<br />

• Anticorps chimériques et humanisés pour<br />

intégrine alpha5 béta1 permettant de<br />

moduler l'angiogénèse<br />

(71) Facet Biotech Corporation, 1400 Seaport<br />

Boulevard, Redwood City, California 94063,<br />

US<br />

(72) Ramakrishnan, Vanitha, Belmont, CA 94002,<br />

US<br />

385<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>31</strong>/<strong>2011</strong>) 03.08.<strong>2011</strong><br />

Powers, David, Fairfax, CA 94930, US<br />

Johnson, Dale E., Emeryville, CA 94608, US<br />

Jeffrey, Ursula, Redwood City, CA 94061, US<br />

(74) Schüssler, Andrea, Truderinger Strasse 246,<br />

81825 München, DE<br />

(62) 03796541.5 / 1 575 516<br />

(51) A61K 39/395 (11) 2 351 584 A1<br />

A61P 35/00 C07K 16/24<br />

G01N 33/53<br />

(25) En (26) En<br />

(21) 10178487.4 (22) 23.12.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(30) 23.12.2003 US 532130 P<br />

(54) • Neue anti-IL 13-Antikörper und Verwendungen<br />

dafür<br />

• Novel anti-IL 13 antibodies and uses<br />

thereof<br />

• Nouveaux anticorps anti-IL 13 et utilisations<br />

associées<br />

(71) Genentech, Inc., 1 DNA Way, South San<br />

Francisco, CA 94080, US<br />

(72) Fung, Sek Chung, Gaithersburg, MD 20878,<br />

US<br />

Moyle, Matthew, Redmond, WA 98052, US<br />

Lu, Mason, Houston, TX 77030, US<br />

Yan, Changning, Houston, TX 77030, US<br />

Singh, Sanjaya, Sandy Hook, Connecticut<br />

06482, US<br />

Huang, Dan, Short Hills, NJ 07078, US<br />

(74) Vossius & Partner, Siebertstrasse 4, 81675<br />

München, DE<br />

(62) 04815562.6 / 1 703 893<br />

A61K 39/395 → (51) A01K 67/027<br />

A61K 39/395 → (51) C07K 16/30<br />

A61K 39/395 → (51) C12N 5/07<br />

A61K 39/395 → (51) C12N 15/09<br />

(51) A61K 45/00 (11) 2 351 585 A1<br />

A61K <strong>31</strong>/7088 A61K <strong>31</strong>/7105<br />

A61K <strong>31</strong>/7115 A61K 48/00<br />

A61P 1/16 A61P <strong>31</strong>/14<br />

A61P 43/00<br />

(25) Ja (26) En<br />

(21) 09810032.4 (22) 28.08.2009<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MK MT<br />

NL NO PL PT RO SE SI SK SM TR<br />

(86) JP 2009/065072 28.08.2009<br />

(87) WO 2010/024384 2010/09 04.03.2010<br />

(30) 29.08.2008 JP 2008221980<br />

(54) • ANTI-HCV-ZUSAMMENSETZUNG<br />

• ANTI-HEPATITIS C VIRUS COMPOSITION<br />

• COMPOSITION D' ANTIVIRUS DE L'<br />

HÉPATITE C<br />

(71) Osaka University, 1-1, Yamadaoka, Suita-shi<br />

Osaka 565-0871, JP<br />

(72) MORIISHI, Kohji, Suita-shi Osaka 565-0871,<br />

JP<br />

MATSUURA, Yoshiharu, Suita-shi Osaka<br />

565-0871, JP<br />

(74) Denison, Christopher Marcus, et al, Mewburn<br />

Ellis LLP 33 Gutter Lane, London EC2V<br />

8AS, GB<br />

A61K 45/00 → (51) A61K <strong>31</strong>/40<br />

A61K 45/00 → (51) C12N 5/07<br />

A61K 47/14 → (51) A61K <strong>31</strong>/4409

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!